Cargando…
Infectious Complications in Autoimmune Hemolytic Anemia
Autoimmune hemolytic anemia (AIHA) may be frequently challenged by infectious complications, mainly as a result of immunosuppressive treatments administered. Furthermore, infectious agents are known triggers of AIHA onset and relapse. Although being risk factors for mortality, infections are an unde...
Autores principales: | Giannotta, Juri Alessandro, Fattizzo, Bruno, Cavallaro, Francesca, Barcellini, Wilma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796467/ https://www.ncbi.nlm.nih.gov/pubmed/33466516 http://dx.doi.org/10.3390/jcm10010164 |
Ejemplares similares
-
Bortezomib in autoimmune hemolytic anemia and beyond
por: Pasquale, Raffaella, et al.
Publicado: (2021) -
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
por: Barcellini, Wilma, et al.
Publicado: (2020) -
Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist
por: Fattizzo, Bruno, et al.
Publicado: (2020) -
Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias
por: Fattizzo, Bruno, et al.
Publicado: (2021) -
Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia
por: Fattizzo, Bruno, et al.
Publicado: (2022)